Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy

PURPOSE: To investigate the 2-year outcomes of three monthly intravitreal ranibizumab injections followed by as-needed reinjections to treat polypoidal choroidal vasculopathy (PCV). METHODS: Seventy-five consecutive eyes with naïve symptomatic PCV with 2 years of follow-up after treatment were studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hikichi, Taiichi, Higuchi, Makoto, Matsushita, Takuro, Kosaka, Shoko, Matsushita, Reiko, Takami, Kimitaka, Ohtsuka, Hideo, Kitamei, Hirokuni, Shioya, Shoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632979/
https://www.ncbi.nlm.nih.gov/pubmed/23428984
http://dx.doi.org/10.1136/bjophthalmol-2012-302652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632979/
https://www.ncbi.nlm.nih.gov/pubmed/23428984
http://dx.doi.org/10.1136/bjophthalmol-2012-302652

Ejemplares similares